Why Is It Important To Avoid Avaforce 50 Mg If You Have Retinitis Pigmentosa?
Avaforce 50 mg (avanafil 50 mg) should be avoided if you have retinitis pigmentosa because this inherited eye disease already damages the retina’s light‑sensitive cells, and PDE5 inhibitors like avanafil can worsen visual disturbances or, in vulnerable patients, potentially accelerate retinal stress. Avanafil works by blocking PDE5, but it also mildly affects PDE6, an enzyme critical for the visual‑cycle pathway in the retina.
In people with retinitis pigmentosa, this additional interference can intensify common Avaforce 50 Mg class side effects such as blurred vision, abnormal color perception, and heightened light sensitivity, which may be more disabling when the retina is already weakened. Some animal‑model studies suggest PDE‑inhibitor exposure can lead to longer‑lasting or delayed visual recovery and early signs of photoreceptor changes in retinas with genetic defects similar to retinitis pigmentosa, even if the damage is subtle.
For safety, regulatory and prescribing guidance explicitly flag retinitis pigmentosa as a condition where PDE5 inhibitors like avanafil (Avaforce 50 mg) should be avoided unless a specialist ophthalmologist and cardiologist jointly judge the risk–benefit acceptable. Any sudden or worsening vision changes after taking such a medicine in a retinitis‑pigmentosa patient must be treated as an emergency and reported immediately.  |